Nicholas N. Vahanian
2015
In 2015, Nicholas N. Vahanian earned a total compensation of $4.2M as President & Chief Medical Officer at NewLink Genetics, a 85% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $305,785 |
|---|---|
| Option Awards | $2,167,018 |
| Salary | $531,800 |
| Stock Awards | $1,091,250 |
| Other | $61,706 |
| Total | $4,157,559 |
Vahanian received $2.2M in option awards, accounting for 52% of the total pay in 2015.
Vahanian also received $305.8K in non-equity incentive plan, $531.8K in salary, $1.1M in stock awards and $61.7K in other compensation.
Rankings
In 2015, Nicholas N. Vahanian's compensation ranked 2,074th out of 13,638 executives tracked by ExecPay. In other words, Vahanian earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,074 out of 13,638 | 85th |
Division Manufacturing | 740 out of 5,190 | 86th |
Major group Chemicals And Allied Products | 268 out of 1,854 | 86th |
Industry group Drugs | 211 out of 1,528 | 86th |
Industry Pharmaceutical Preparations | 168 out of 1,182 | 86th |
Source: SEC filing on March 31, 2017.
Vahanian's colleagues
We found five more compensation records of executives who worked with Nicholas N. Vahanian at NewLink Genetics in 2015.
2015
Charles Link
NewLink Genetics
Chief Executive & Scientific Officer
2015
Brian Wiley
NewLink Genetics
Chief Commercial Officer
2015
Eugene Kennedy
NewLink Genetics
Chief Medical Officer
2015
Carl Langren
NewLink Genetics
Vice President of Finance
2015
John Henneman
NewLink Genetics